Related Experiment Video
Updated: Jul 5, 2025

Diagonal Method to Measure Synergy Among Any Number of Drugs
Published on: June 21, 2018
Unlocking the therapeutic potential of drug combinations through synergy prediction using graph transformer networks
Waleed Alam1, Hilal Tayara2, Kil To Chong3
1Department of Electronics and Information Engineering, Jeonbuk National University, Jeonju, 54896, South Korea.
Abstract:
Drug combinations are frequently used to treat cancer to reduce side effects and increase efficacy. The experimental discovery of drug combination synergy is time-consuming and expensive for large datasets. Therefore, an efficient and reliable computational approach is required to investigate these drug combinations. Advancements in deep learning can handle large datasets with various biological problems. In this study, we developed a SynergyGTN model based on the Graph Transformer Network to predict the synergistic drug combinations against an untreated cancer cell line expression profile. We represent the drug via a graph, with each node and edge of the graph containing nine types of atomic feature vectors and four bonds features, respectively. The cell lines represent based on their gene expression profiles. The drug graph was passed through the GTN layers to extract a generalized feature map for each drug pairs. The drug pair extracted features and cell-line gene expression profiles were concatenated and subsequently subjected to processing through multiple densely connected layers. SynergyGTN outperformed the state-of-the-art methods, with a receiver operating characteristic area under the curve improvement of 5% on the 5-fold cross-validation. The accuracy of SynergyGTN was further verified through three types of cross-validation tests strategies namely leave-drug-out, leave-combination-out, and leave-tissue-out, resulting in improvement in accuracy of 8%, 1%, and 2%, respectively. The Astrazeneca Dream dataset was utilized as an independent dataset to validate and assess the generalizability of the proposed method, resulting in an improvement in balanced accuracy of 13%. In conclusion, SynergyGTN is a reliable and efficient computational approach for predicting drug combination synergy in cancer treatment. Finally, we developed a web server tool to facilitate the pharmaceutical industry and researchers, as available at: http://nsclbio.jbnu.ac.kr/tools/SynergyGTN/.
Insights
A new computational model, SynergyGTN, uses deep learning to predict synergistic drug combinations for cancer treatment. This approach is more efficient and accurate than existing methods, aiding drug discovery.
Area of Science:
- Computational biology
- Bioinformatics
- Drug discovery
Background:
- Drug combinations are crucial for cancer therapy, improving efficacy and reducing side effects.
- Experimental identification of synergistic drug combinations is costly and time-consuming for large datasets.
- Deep learning offers a powerful computational approach for analyzing complex biological data.
Purpose of the Study:
- To develop an efficient and reliable computational model for predicting synergistic drug combinations against cancer cell lines.
- To leverage Graph Transformer Networks (GTN) for drug synergy prediction.
Main Methods:
- Developed SynergyGTN, a model based on Graph Transformer Network (GTN).
- Represented drugs as graphs with atomic feature vectors and bond features.
- Integrated drug graph features with cancer cell line gene expression profiles.
- Utilized densely connected layers for final prediction.
Main Results:
- SynergyGTN demonstrated superior performance compared to state-of-the-art methods.
- Achieved a 5% improvement in receiver operating characteristic area under the curve (ROC AUC) via 5-fold cross-validation.
- Showcased enhanced accuracy across leave-drug-out (8%), leave-combination-out (1%), and leave-tissue-out (2%) validation strategies.
- Validated generalizability on the Astrazeneca Dream dataset, yielding a 13% improvement in balanced accuracy.
Conclusions:
- SynergyGTN provides a reliable and efficient computational method for predicting synergistic drug combinations in cancer treatment.
- The developed SynergyGTN model and its associated web server tool can significantly aid the pharmaceutical industry and researchers in drug discovery efforts.
Related Concept Videos
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Agonism and Antagonism: Quantification
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
Drug Discovery: Overview
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Combined Effects of Drugs: Antagonism
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...

